We've found
4,191
archived clinical trials in
Constipation
We've found
4,191
archived clinical trials in
Constipation
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Updated: 12/31/1969
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
Updated: 12/31/1969
A Double-blind, Randomized, Placebo-controlled Trial of Naloxegol for Prevention of Post-operative Constipation in Spinal Surgery Patients
Status: Enrolling
Updated: 12/31/1969
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
Updated: 12/31/1969
A Double-blind, Randomized, Placebo-controlled Trial of Naloxegol for Prevention of Post-operative Constipation in Spinal Surgery Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Updated: 12/31/1969
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Updated: 12/31/1969
A Randomized, Single Center, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Status: Enrolling
Updated: 12/31/1969
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Updated: 12/31/1969
A Randomized, Single Center, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
Updated: 12/31/1969
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
Updated: 12/31/1969
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
Updated: 12/31/1969
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
Updated: 12/31/1969
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
Updated: 12/31/1969
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
Updated: 12/31/1969
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials